Marvel Highlights New Published Research of Its SAB Member Professor David Blum @marvelbiotechnology #Chemicals #Biotechnology #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice" by a member of its scientific advisory board, Dr. David Blum and colleagues (PMID 3896478). In this study, published in the leading neurological journal...
http://dlvr.it/T9MhWb
http://dlvr.it/T9MhWb
Comments
Post a Comment